Meticulous Research®, a prominent market research firm, has recently released a report titled “Europe Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Forecast to 2030.” According to this latest report, the Europe molecular diagnostics market is expected to reach $13.25 billion by 2030, growing at a compound annual growth rate (CAGR) of 4% from 2024 to 2030.

Request Sample Report  @  https://www.meticulousresearch.com/download-sample-report/cp_id=5710

Several factors are driving this market's growth, including technological advancements in molecular diagnostics, the increasing adoption of point-of-care (PoC) diagnostic tests, rising funding for research and development in diagnostic products, the growing elderly population, and the increasing prevalence of targeted diseases. However, the market faces challenges such as a complex regulatory environment and the high cost of molecular diagnostic tests, which could impede its growth. On a positive note, the development of companion diagnostics presents substantial opportunities for industry players. Nonetheless, a significant challenge remains in the shortage of skilled professionals in the field.

Key Players in the Market

Leading companies in the Europe molecular diagnostics market include F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (U.S.), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Illumina, Inc. (U.S.).

Market Segmentation

The Europe molecular diagnostics market is categorized by product and service, test type, technology, application, end user, and geography. In terms of product and service, the market is divided into kits and reagents, instruments, and software and services. Test types include laboratory-based tests and point-of-care (PoC) tests. Technology segments cover Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), microarrays, mass spectrometry, sequencing, and other technologies.

Regarding applications, the market is segmented into infectious diseases (including COVID-19, hepatitis, HIV, healthcare-associated infections, and more), oncology (covering various cancers such as breast, colorectal, lung, prostate, and others), genetic testing, neurological diseases, cardiovascular diseases, and other applications. End users of molecular diagnostics include hospitals and clinics, diagnostic laboratories, academic and research institutes, and other healthcare facilities.

This comprehensive analysis also covers industry competitors and evaluates country-level markets across Europe, providing insights into regional growth trends and market dynamics.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research